E E Epson1, A Cronquist2, K Lamba3, A C Kimura3, R Hassan4, D Selvage5, C S McNeil6, A K Varan7, J L Silvaggio8, L Fan9, X Tong9, P R Spradling10. 1. Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA; Colorado Department of Public Health and Environment, Denver, CO, USA. Electronic address: Erin.Epson@cdph.ca.gov. 2. Colorado Department of Public Health and Environment, Denver, CO, USA. 3. California Department of Public Health, Richmond, CA, USA. 4. Arizona Department of Health Services, Phoenix, AZ, USA. 5. New Mexico Department of Health, Santa Fe, NM, USA. 6. Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA; New Mexico Department of Health, Santa Fe, NM, USA. 7. County of San Diego Health and Human Services Agency, San Diego, CA, USA; Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, GA, USA. 8. CDC/CSTE Applied Epidemiology Fellowship Program, Atlanta, GA, USA; Los Angeles County Department of Public Health, Acute Communicable Disease Control Program, Los Angeles, CA, USA. 9. Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, USA. 10. Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: pspradling@cdc.gov.
Abstract
OBJECTIVES: To assess hospitalisation risk factors and economic effects associated with a multistate hepatitis A outbreak in 2013. STUDY DESIGN: Retrospective case series. METHODS: Eligible outbreak-related cases confirmed by September 1, 2013, were defined as acute hepatitis symptoms and positive IgM anti-hepatitis A during March 15-August 12 among patients who consumed the food vehicle or had the outbreak genotype. We reviewed medical records, comparing demographic and clinical characteristics among hospitalized and non-hospitalized patients; we used logistic regression analysis to identify factors associated with hospitalization. We interviewed patients regarding symptom duration and healthcare usage and estimated per-patient and total costs. Health departments reported outbreak-related personnel hours. RESULTS: Medical records were reviewed for 147/159 (92%) eligible patients; median age was 48 (range: 1-84) years, and 64 (44%) patients were hospitalized. Having any chronic medical condition was independently associated with hospitalisation (odds ratio, 3.80; 95% confidence interval, 1.68-8.62). Interviews were completed for 114 (72%) eligible patients; estimated per-patient cost of healthcare and productivity loss was $13,467 for hospitalized and $2138 for non-hospitalized patients and $1,304,648 for all 165 outbreak-related cases. State and local public health personnel expenditures included 82 h and $3221/outbreak-related case. CONCLUSIONS: Hospitalisations in this outbreak were associated with chronic medical conditions and resulted in substantial healthcare usage and lost productivity. These data can be used to inform future evaluation of expansion of hepatitis A vaccination recommendations to include adults with chronic medical conditions. Published by Elsevier Ltd.
OBJECTIVES: To assess hospitalisation risk factors and economic effects associated with a multistate hepatitis A outbreak in 2013. STUDY DESIGN: Retrospective case series. METHODS: Eligible outbreak-related cases confirmed by September 1, 2013, were defined as acute hepatitis symptoms and positive IgM anti-hepatitis A during March 15-August 12 among patients who consumed the food vehicle or had the outbreak genotype. We reviewed medical records, comparing demographic and clinical characteristics among hospitalized and non-hospitalized patients; we used logistic regression analysis to identify factors associated with hospitalization. We interviewed patients regarding symptom duration and healthcare usage and estimated per-patient and total costs. Health departments reported outbreak-related personnel hours. RESULTS: Medical records were reviewed for 147/159 (92%) eligible patients; median age was 48 (range: 1-84) years, and 64 (44%) patients were hospitalized. Having any chronic medical condition was independently associated with hospitalisation (odds ratio, 3.80; 95% confidence interval, 1.68-8.62). Interviews were completed for 114 (72%) eligible patients; estimated per-patient cost of healthcare and productivity loss was $13,467 for hospitalized and $2138 for non-hospitalized patients and $1,304,648 for all 165 outbreak-related cases. State and local public health personnel expenditures included 82 h and $3221/outbreak-related case. CONCLUSIONS: Hospitalisations in this outbreak were associated with chronic medical conditions and resulted in substantial healthcare usage and lost productivity. These data can be used to inform future evaluation of expansion of hepatitis A vaccination recommendations to include adults with chronic medical conditions. Published by Elsevier Ltd.
Entities:
Keywords:
Disease outbreaks; Health economics and organizations; Hepatitis A
Authors: R Monina Klevens; Jeremy T Miller; Kashif Iqbal; Ann Thomas; Elena M Rizzo; Heather Hanson; Kristin Sweet; Quyen Phan; Alicia Cronquist; Yury Khudyakov; Guo-liang Xia; Philip Spradling Journal: Arch Intern Med Date: 2010-11-08
Authors: Charlotte Wheeler; Tara M Vogt; Gregory L Armstrong; Gilberto Vaughan; Andre Weltman; Omana V Nainan; Virginia Dato; Guoliang Xia; Kirsten Waller; Joseph Amon; Teresa M Lee; Angela Highbaugh-Battle; Cambria Hembree; Stephanie Evenson; Michael A Ruta; Ian T Williams; Anthony E Fiore; Beth P Bell Journal: N Engl J Med Date: 2005-09-01 Impact factor: 91.245
Authors: C M Dentinger; W A Bower; O V Nainan; S M Cotter; G Myers; L M Dubusky; S Fowler; E D Salehi; B P Bell Journal: J Infect Dis Date: 2001-03-26 Impact factor: 5.226
Authors: Melissa G Collier; Yury E Khudyakov; David Selvage; Meg Adams-Cameron; Erin Epson; Alicia Cronquist; Rachel H Jervis; Katherine Lamba; Akiko C Kimura; Rick Sowadsky; Rashida Hassan; Sarah Y Park; Eric Garza; Aleisha J Elliott; David S Rotstein; Jennifer Beal; Thomas Kuntz; Susan E Lance; Rebecca Dreisch; Matthew E Wise; Noele P Nelson; Anil Suryaprasad; Jan Drobeniuc; Scott D Holmberg; Fujie Xu Journal: Lancet Infect Dis Date: 2014-09-03 Impact factor: 25.071